AI-generated summary
The authors studied whether photobiomodulation with a class 3b laser causes premature release of liposomal bupivacaine in a single dog cadaver, testing six power and energy settings plus a sham. They report no difference in free bupivacaine concentrations between groups. The authors note the work is a proof-of-concept study and that in vivo studies at similar and stronger settings are warranted.
- Who or what was studied
- One 25-kg mixed breed dog cadaver, with liposomal bupivacaine samples tested in vitro after laser treatment
- Limits stated in the abstract
- The study used a single dog cadaver and proof-of-concept design, and the abstract states that in vivo studies are needed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on avmajournals.avma.org.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 2.0 J/cm2, 4.0 J/cm2, 6.0 J/cm2, 0.0 J/cm2
- Power
- 0.5 W, 1.0 W, 0.0 W
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Laser, Photobiomodulation therapy, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.